Does BISOPROLOL Cause Interstitial lung disease? 326 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 326 reports of Interstitial lung disease have been filed in association with BISOPROLOL (bisoprolol fumarate and hydrochlorothiazide). This represents 1.2% of all adverse event reports for BISOPROLOL.
326
Reports of Interstitial lung disease with BISOPROLOL
1.2%
of all BISOPROLOL reports
55
Deaths
239
Hospitalizations
How Dangerous Is Interstitial lung disease From BISOPROLOL?
Of the 326 reports, 55 (16.9%) resulted in death, 239 (73.3%) required hospitalization, and 36 (11.0%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BISOPROLOL. However, 326 reports have been filed with the FAERS database.
What Other Side Effects Does BISOPROLOL Cause?
Dyspnoea (2,940)
Bradycardia (2,535)
Hypotension (2,504)
Dizziness (2,153)
Fall (2,011)
Fatigue (1,983)
Acute kidney injury (1,894)
Malaise (1,602)
Drug ineffective (1,486)
Nausea (1,460)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which BISOPROLOL Alternatives Have Lower Interstitial lung disease Risk?
BISOPROLOL vs BISOPROLOL\BISOPROLOL
BISOPROLOL vs BISOPROLOL\HYDROCHLOROTHIAZIDE
BISOPROLOL vs BIVALIRUDIN
BISOPROLOL vs BLEOMYCIN
BISOPROLOL vs BLINATUMOMAB